CN108379386A - A kind of Chinese medicine for treating blood-heat type anaphylactoid purpura - Google Patents
A kind of Chinese medicine for treating blood-heat type anaphylactoid purpura Download PDFInfo
- Publication number
- CN108379386A CN108379386A CN201810540744.0A CN201810540744A CN108379386A CN 108379386 A CN108379386 A CN 108379386A CN 201810540744 A CN201810540744 A CN 201810540744A CN 108379386 A CN108379386 A CN 108379386A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- purpura
- chinese medicine
- heat type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Abstract
The invention discloses a kind of Chinese medicines for treating blood-heat type anaphylactoid purpura, are made of the bulk pharmaceutical chemicals of following parts by weight：10 15 parts of radix rehmanniae recen, 6 10 parts of moutan bark, 6 10 parts of Asian puccoon, 6 10 parts of Radix Paeoniae Alba, 9 12 parts of caulis trachelospermi, 15 30 parts of caulis lonicerae, 6 10 parts of Rhizoma Chuanxiong, 6 parts of honey-fried licorice root.For the present invention based on clearing heat and cooling blood, promoting blood circulation ecchymose removing, compatibility is exquisite, and simplicity is tested honest and clean, has and adjusts immune and antianaphylactic effect, curative for effect, few side effects, safe ready.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicines more particularly to a kind of Chinese medicines for treating blood-heat type anaphylactoid purpura.
Background technology
Anaphylactoid purpura is a kind of blood vessel allergy hemorrhagic disease, that is, immunity vascular conditions.It is fallen ill
Mainly due to body to Cucumber allergy occurs for mechanism, and the permeability of capillary wall and brittleness is caused to increase, and
With polyangitis.This disease can be caused by many factors, may with bacterium, virus protein, parasite metabolite, food and
Some drugs etc. are related.Its clinical manifestation is mainly skin or mucosal bleeding, arthritis, abdominal pain, ephritis etc..
The characteristics of anaphylactoid purpura is fallen ill according to it can be mainly divided into following several types：
1, simple form
It is most common type, is mainly shown as skin purpura, purpura is not of uniform size, can merge in flakes, forms ecchymosis, main
Four limbs, especially lower limb and buttocks are confined to, trunk seldom occurs, can be simultaneously with hydroderma, nettle rash, through 7-14 days
Gradually subside.
2, abdomen type
In addition to skin purpura, because gastrointestinal mucosal and peritonaeum viscerale capillary are involved, and a series of alimentary canal diseases are generated
Shape and sign (about 2/3 patient generation), such as：Nausea and vomiting, spitting blood, diarrhea and Mucous Stool are had blood in stool.Wherein abdominal pain is the most normal
See, be often paroxysmal colic, multidigit can be hyperfunction because of tension of abdominal muscle and apparent tenderness, gurgling sound in navel week, lower abdomen or full abdomen, breaking-out
And mistaken diagnosis is Surgical Acute Venter Diseases.Entembole is caused in child's Ke Yin intestinal walls oedema, wriggling enhancing etc..Abdominal symptoms, sign mostly with
Skin purpura occurs simultaneously, before can occasionally betiding purpura.
3, joint type
In addition to skin purpura, because there are the performances such as arthroncus, pain, tenderness and dysfunction in joint part vascular involvement
(about 1/2 patient has joint symptoms), mostly occurs in the large joints such as knee, ankle, wrist, elbow, and arthroncus is generally relatively light, in migrans,
Recurrent exerbation is cured through a few days, does not leave joint deformity.
4, kidney type
The state of an illness is the most serious, and incidence is up to patient 30%-60%.In addition to skin purpura, because of glomerular capillary inflammation
Property reaction and there is blood urine, albuminuria and cylindruria.Renal symptom may occur in which any period in disease, but after being occurred with purpura
One week common.It is generally acknowledged that urine variation appearance is more early, the process of ephritis is heavier, and a small number of cases develop into chronic because of recurrent exerbation
Ephritis (blood urine, albuminuria, oedema, hypertension), nephrotic syndrome, low plasma albumin mass formed by blood stasis.
5, mixed type
I.e. other than skin purpura, there is can existing simultaneously for amphitypy or amphitypy or more in other three types.
Other symptoms：Accidental cerebral hemorrhage, then may occur in which convulsions, temporary paralysis, aphasia etc., and severe patient can cause death.
Other seldom see such as nosebleed, bleeding gums, hemorrhage of muscle, testis swelling bleeding or Pulmonary hemosiderosis calmness etc..
Treatment blood-heat type anaphylactoid purpura commonly uses single western medicine therapy at present, mainly small with anti-infective, antiallergy, anti-blood
Plate, which is assembled and inhibits immune, to be waited based on symptomatic treatments, but high recurrence rate, side effect are big.
Invention content
It is an object of the invention to overcome current treatment blood-heat type anaphylactoid purpura to commonly use single western medicine therapy, recurrence rate
Height, the big defect of side effect provide a kind of Chinese medicine for treating blood-heat type anaphylactoid purpura, are with clearing heat and cooling blood, promoting blood circulation ecchymose removing
Main, compatibility is exquisite, and simplicity is tested honest and clean, has and adjusts immune and antianaphylactic effect, curative for effect, few side effects, safe ready.
In order to achieve the above object, the present invention is according to traditional Chinese medical theory, using the unique pharmacological property of Chinese medicine, using radix rehmanniae recen,
The bulk pharmaceutical chemicals such as moutan bark, Asian puccoon, Radix Paeoniae Alba, caulis trachelospermi, caulis lonicerae, Rhizoma Chuanxiong, honey-fried licorice root are made according to certain compatibility requirements.
Chinese medicine of the present invention is prepared to be made of the bulk pharmaceutical chemicals of following parts by weight：10-15 parts of radix rehmanniae recen, 6-10 parts of moutan bark, purple
6-10 parts careless, 6-10 parts of Radix Paeoniae Alba, 9-12 parts of caulis trachelospermi, 15-30 parts of caulis lonicerae, 6-10 parts of Rhizoma Chuanxiong, 6 parts of honey-fried licorice root.
Optimum weight part of Chinese medicine material medicine of the present invention is：15 parts of radix rehmanniae recen, 10 parts of moutan bark, 10 parts of Asian puccoon, Radix Paeoniae Alba 10
Part, 10 parts of caulis trachelospermi, 15 parts of caulis lonicerae, 10 parts of Rhizoma Chuanxiong, 6 parts of honey-fried licorice root.
The pharmacological action of Chinese medicine of the present invention is as follows：
Radix rehmanniae recen
Nature and flavor are sweet, cold.The thoughts of returning home, liver and kidney channel.Effect：Clearing heat and cooling blood, nourishing Yin and promoting production of body fluid.For the deep red polydipsia of pyreticosis tongue, in the deficiency of Yin
Heat, osteopyrexia and fever, Heat Diabetes are spitted blood, spot dermexanthesis.Modern pharmacological studies have shown that it has decompression, calmness, anti-inflammatory, anti-mistake
The effects that quick, cardiac stimulant, diuresis, can promote the conversion of body lymphoblast, increase the quantity of T lymphocytes, enhance in netted
The phagocytosis of chrotoplast, immunity-regulating.
Moutan bark
It is bitter in taste, pungent, be slightly cold.The thoughts of returning home, liver and kidney channel.Effect：Clearing heat and cooling blood, it is promoting blood circulation and removing blood stasis.Enter ying blood, epidemic heat syndrome for heat
Macular eruption spits blood and stores blood, night fever abating at dawn, lossless hectic fever due to yin, closed dysmenorrhea, injury from falling down, carbuncle sore tumefacting virus.Modern pharmacological studies have shown that
It has the effects that anti-inflammatory, inhibition platelet aggregation, antiallergy, also can inhibit the permeability of capillary.
Asian puccoon
Nature and flavor are sweet, salty, cold, converge to heart and liver channels.Effect：Clearing heat and cooling blood, promoting blood circulation and detoxication, promoting eruption ecchymose removing.For blood-heat and toxin exuberance,
Atropurpureus macula, measles without adequate eruption, sore, eczema, scald.Modern pharmacological studies have shown that it can reduce capillary permeability,
Inhibit local edema, the vasopermeability for oozing out the phase to inflammation Acute increases, ooze out and oedema and proliferation period inflammation have antagonism
Effect.
Radix Paeoniae Alba
It is bitter in taste, sour, be slightly cold.Return liver, the spleen channel.Effect：Nourishing blood for regulating menstruation, astringing YIN to stop sweating, soft liver analgesic, suppressing liver-YANG.With
In blood deficiency chlorosis, irregular menstruation, spontaneous perspiration, night sweat, hypochondriac pain, abdominal pain, four limbs contraction pain, dizziness of having a headache.Modern pharmacological studies have shown that white
Active ingredient in Chinese herbaceous peony is white peony root's total glycoside, and the generation of interleukin 1 is adjusted, thus is adjusted with immune with significantly anti-inflammatory
Section acts on.
Caulis trachelospermi
It is bitter in taste, be slightly cold.The thoughts of returning home, liver and kidney channel.Effect：Dispelling wind and removing obstruction in the meridians, cool blood detumescence.For beriberoid pyretic arthralgia, tendon and vessel is arrested
Contraction, soreness of waist and knee joint, larynx numbness, carbuncle swells, injury from falling down.Modern pharmacological studies have shown that it mainly contains flavonoids, lignanoids, triterpene
The compounds such as class have antifatigue, anti-inflammatory and antalgic, the effect of phytoestrogen sample and anti-cancer, active anticancer effect.
Caulis lonicerae
Nature and flavor are sweet, cold.It attaches to the lung and stomach meridians.Effect：It is clearing heat and detoxicating, dispelling wind dredging collateral.For warm disease heating, toxic-heat and blood stasis, carbuncle swells
Sore, beriberoid pyretic arthralgia, redness and swelling of joints heat pain.Modern pharmacological studies have shown that its ingredient has the substances such as lonicerin, honeysuckle element, medicine
Reason shows as anti-inflammatory analgesic, inhibits humoral immunity, inhibits the effects that platelet aggregation, antiallergy, antiallergic action.
Rhizoma Chuanxiong
Nature and flavor are pungent, warm.Return liver, courage, pericardium channel.Effect：Blood-activating and qi-promoting, wind-expelling pain-stopping.For chest impediment and cardialgia, chest side of body thorn
Bitterly, tumbling and swelling, irregular menstruation, closed dysmenorrhea , Disorder lump in the abdomen is suffered from abdominal pain, headache, arthralgia pain due to rheumatism.Modern pharmacological studies have shown that in Rhizoma Chuanxiong
Active ingredient such as ligustrazine and ferulic acid etc., there is scavenging activated oxygen, expand blood vessel, platelet aggregation-against and antithrombus formation
Pharmacological action.
Honey-fried licorice root
Nature and flavor are sweet, flat.The thoughts of returning home, lung, spleen, stomach.Effect：It invigorates the spleen and benefits qi, clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain is adjusted
With all medicines.For weakness of the spleen and the stomach, lassitude hypodynamia, palpitation, coughing with a lot of sputum, gastral cavity abdomen, four limbs contraction, carbuncle sore tumefacting virus, delay
Solve drug toxicity, strong.Modern pharmacological studies have shown that its main component is glycyrrhizin, enoxolone and a variety of flavones, there is town
Quiet and adrenocortical hormones fuction, the anti-inflammatory, antiallergic action of energy, and the early lesion and vascular lesion of kidney can be prevented,
Also play the role of dropping urea nitrogen, enoxolone and general flavone can alleviate gastrointestinal smooth spasm, gastric acid secretion inhibiting.
Anaphylactoid purpura belongs to Chinese medicine " mass formed by blood stasis ", " purple plague purpura ", " flesh nosebleed ", " ecchynosis " scope, morbidity with " wind ", " heat ",
Based on " poison ", the common anemopyretic of card type and blood-heat type.Blood-heat type infant skin purpura color and luster is scarlet, or with nosebleed epistaxis, bleeding from the gum, just
Blood, hematuria, color is scarlet or purplish red, while seeing vexed, thirsty, constipation, or with abdominal pain, or has fever, and tongue is red, yellow tongue fur, rapid pulse
Effectively.It is found by clinical practice, the present invention has blood-heat type anaphylactoid purpura unique curative effect, reaches treatment blood-heat type mistake
The purpose of sensitive purpura.
The beneficial effects of the present invention will now be described with reference to clinical experimental data：
1 clinical data
In January, -2018 in January, 2013 blood-heat type patients with anaphylactoid purpura case, treatment group 100 are acquired in purpura outpatient service
Example, wherein male 54, women 46, age 7-21 Sui, average age 16.4 years old, course of disease 1-60 days.Control group 100,
Middle male 51, female 49, age 8-20 Sui, average age 17.0 years old, course of disease 1-60 days.Two groups of patients are in gender, age, the course of disease
Aspect does not have significant significant difference, is comparable.
1.1 inclusion criteria
1. meeting the Western medicine diagnostic criteria of anaphylactoid purpura, Syndrome Differentiation of Traditional Chinese Medicine category blood-heat bleeding card；2. purpura is initial, not
Use the immunosuppressant treatments such as Tripterygium wilfordii Polyglycosidium Tablets, elder brother's celestial being capsule, leflunomide tablet, hormone；3. routine urinalysis is normal；4. I
Or legal guardian agrees to and signed informed consent form.
1.2 exclusion criteria
1. being associated with the diseases patient such as hepatic and kidney function obstacle, continuous hypertension；2. pigmentation purpura and decrease of platelet
Property purpura infant；3. card type conversion person in therapeutic process, such as the blood-heat syndrome person that is converted into syndrome of deficiency of both qi and yin；4. to drug mistake of the present invention
Quick person.
The movement of 1.3 diet pays attention to
Avoid pungent food during taking medicine on diet, seafood, mutton, mango, the foods such as durian, pays attention to that meat and vegetables collocation, purpura are steady
It can be by adding meat, egg, milk etc. after can not determining 10 days or more.Movable upper acute stage, should be noted that appropriate rest, avoid aggravating activities, stablize
Phase can normal activity.
2 treatments
Treatment group：The oral present invention is according to decoction made from specific embodiment 2,3 times a day, continuous use 2 weeks.Control
Group：Oral Loratadine, takes to specifications, continuous treatment 2 weeks.
3 curative effect determinate standards
With reference to State Administration of Traditional Chinese Medicine's approval publication in 2012《Disease of tcm Standardization of diagnosis and curative effect》(ZY/T001.1-
94)：
(1) clinical cure (alleviation)：Arthralgia, abdominal pain hour during medication, skin purpura disappear, 2 weeks nothing repeatedly or
Only a few needle point size skin purpura newly goes out after activity；Urine proteins or twenty-four-hour urine protein quantification are normal；Urine erythrocyte counts just
Often；
(2) effective：Arthralgia, abdominal pain disappear during medication, and skin purpura significantly reduces 80% or more；Urine proteins or 24
Hour quantity of proteinuria is normal；Urine erythrocyte counts normal；
(3) it improves：Arthralgia, abdominal pain disappear during medication, and skin purpura reduces 50% or more；Urine proteins or 24 hours
Quantity of proteinuria is normal；Urine erythrocyte counts normal.
(4) invalid：Arthralgia, colic symptoms reduce 50% without alleviating or alleviating unobvious, skin purpura during medication
Below or increase, Urine proteins or twenty-four-hour urine protein quantification are abnormal；Or urine erythrocyte counting of abnormal.
4 results
Treatment group fully recovers 75, effective 12, improves 9, invalid 4, total effective rate 96%.Control group：Control group is fullyed recover from an illness
More it 48, effective 8, improves 16, invalid 28, total effective rate 72%.Two groups of curative effects compare, the total effective rate for the treatment of group
It is significantly higher than control group, P ＜ 0.05.
Typical case
1, Mr. Wang, male, 12 years old, in March, 2013 was medical because " double lower limb fash 10 days " is chief complaint, and occurs after diseases caused by external factors before 10 days
Moderate double lower limb fash, grain of rice size, no arthralgia and abdominal pain, receive dormancy can, two just adjust.Blood urine is routinely showed no apparent different
Often.After taking 2 courses for the treatment of of Chinese medicine of the present invention, Schultz-Charlton, 3 years no relapse of follow-up.
2, flood certain, female, 11 years old, in January, 2017 was because " more than 10 day of double lower limb skin purpura " be chief complaint medical, infant before 10 days
Occurs double lower limb fash after flu, the conventional prompt that has urine examined occults blood+1, protein negative, and fash fades after giving antiphlogistic intravenous infusion 1 week, existing
Double lower limb still has fash with incrustation, partially dry, urine tune of defecating.After taking 4 courses for the treatment of of Chinese medicine of the present invention, clinical symptoms disappear completely
It loses, no recurrence was observed during the follow-up period of 6 months.
Specific implementation mode
In order to better understand with the implementation present invention, further illustrated the present invention with reference to specific embodiment.
Embodiment 1
It weighs：Radix rehmanniae recen 10g, moutan bark 10g, Asian puccoon 10g, Radix Paeoniae Alba 10g, caulis trachelospermi 12g, caulis lonicerae 15g, Rhizoma Chuanxiong 10g,
Honey-fried licorice root 6g.
Usage：Add 8 times of amount water, impregnate 30min, decocts 30min, filtering；Filter residue adds 6 times of amount water, decocts 20min, filtering；
Merging filtrate, mixing, two parts of average mark obtain decoction.
It is blood-heat type person for treating Allergic Purpura in Children Chinese medical discrimination.It takes orally when treatment, is taken twice sooner or later per bu
With 7 days 1 courses for the treatment of, the usual 2-4 course for the treatment of can cure.
Embodiment 2
It weighs：Radix rehmanniae recen 15g, moutan bark 10g, Asian puccoon 10g, Radix Paeoniae Alba 10g, caulis trachelospermi 10g, caulis lonicerae 15g, Rhizoma Chuanxiong 10g,
Honey-fried licorice root 6g.
Usage：Add 8 times of amount water, impregnate 30min, decocts 1h, filtering；Filter residue adds 6 times of amount water, decocts 30min, filtering；It closes
And filtrate, mixing, three parts of average mark obtain decoction.
It is blood-heat type person for treating Allergic Purpura in Children Chinese medical discrimination.It is taken orally when treatment, in the morning, afternoon and evening three times per bu
It takes, 7 days 1 courses for the treatment of, the usual 2-4 course for the treatment of can cure.
Embodiment 3
It weighs：Radix rehmanniae recen 15g, moutan bark 6g, Asian puccoon 6g, Radix Paeoniae Alba 6g, caulis trachelospermi 9g, caulis lonicerae 30g, Rhizoma Chuanxiong 6g, toast are sweet
Careless 6g.
Usage：7 times of amount above-mentioned raw materials medicines are weighed, adds water 2800mL, impregnates 30min；Soaked drug is transferred to two
In decoction decocting machine, set temperature：100 DEG C -115 DEG C, the pan-fried time is set as 20min, and two pan-fried times were 15min, and setting is boiled medicine
Secondary number is 7 pairs, two pan-fried amount of water 850mL；The liquid decocted is packed with packing machine, 200mL/ bags, totally 14 bags, obtains decoction.
It is blood-heat type person for treating Allergic Purpura in Children Chinese medical discrimination.It is taken orally when treatment, 2 times a day, once a bag, 7
Its 1 course for the treatment of, the usual 2-4 course for the treatment of can cure.
The present invention is had the advantages that by being formulated the Chinese medicine made above：
For the present invention based on clearing heat and cooling blood, promoting blood circulation ecchymose removing, compatibility is exquisite, and simplicity is tested honest and clean, has and adjusts immune and antiallergy
Effect, curative for effect, few side effects, safe ready.
It should be understood that the above-mentioned specific implementation mode of the present invention is used only for exemplary illustration or explains the present invention's
Principle, but not to limit the present invention.Therefore, that is done without departing from the spirit and scope of the present invention is any
Modification, equivalent replacement, improvement etc., should all be included in the protection scope of the present invention.
Claims (2)
1. a kind of Chinese medicine for treating blood-heat type anaphylactoid purpura, which is characterized in that be made of the bulk pharmaceutical chemicals of following parts by weight：Radix Rehmanniae
10-15 parts yellow, 6-10 parts of moutan bark, 6-10 parts of Asian puccoon, 6-10 parts of Radix Paeoniae Alba, 9-12 parts of caulis trachelospermi, 15-30 parts of caulis lonicerae, Rhizoma Chuanxiong
6-10 parts, 6 parts of honey-fried licorice root.
2. the Chinese medicine for the treatment of blood-heat type anaphylactoid purpura according to claim 1, which is characterized in that by following parts by weight
Bulk pharmaceutical chemicals are made：15 parts of radix rehmanniae recen, 10 parts of moutan bark, 10 parts of Asian puccoon, 10 parts of Radix Paeoniae Alba, 10 parts of caulis trachelospermi, 15 parts of caulis lonicerae, Rhizoma Chuanxiong
10 parts, 6 parts of honey-fried licorice root.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810540744.0A CN108379386A (en) | 2018-05-30 | 2018-05-30 | A kind of Chinese medicine for treating blood-heat type anaphylactoid purpura |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810540744.0A CN108379386A (en) | 2018-05-30 | 2018-05-30 | A kind of Chinese medicine for treating blood-heat type anaphylactoid purpura |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108379386A true CN108379386A (en) | 2018-08-10 |
Family
ID=63071549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810540744.0A Pending CN108379386A (en) | 2018-05-30 | 2018-05-30 | A kind of Chinese medicine for treating blood-heat type anaphylactoid purpura |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108379386A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104688917A (en) * | 2015-03-28 | 2015-06-10 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for curing anaphylactoid purpura |
-
2018
- 2018-05-30 CN CN201810540744.0A patent/CN108379386A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104688917A (en) * | 2015-03-28 | 2015-06-10 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for curing anaphylactoid purpura |
Non-Patent Citations (5)
| Title |
|---|
| 《中国中医药年鉴》编辑委员会: "《中国中医药年鉴》", 31 January 1994, 中国中医药出版社 * |
| GAVIN FALK, M.D ET AL.: "AN UNEXPECTED DEVELOPMENT AFTER SURGERY–POST-TRANSFUSION PURPURA!", 《AMERICAN JOURNAL OF HEMATOLOGY》 * |
| H***: "混合型过敏性紫癜检查哪些项目呢请问任主任需要检查哪些项目", 《HTTPS://WWW.HAODF.COM/WENDA/RENXQ723_G_5702782600_P_2.HTM》 * |
| 邱德亮: "《吉林名中医•医案卷》", 31 December 2014, 吉林科学技术出版社 * |
| 郑海涛等: "丁樱教授应用藤类药物治疗过敏性紫癜撷菁", 《光明中医》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488849A (en) | Traditional Chinese medicine composition used for treating periodontitis | |
| CN108210791A (en) | For treating the Chinese medicine of gout and preparation method | |
| CN103013806B (en) | Health-care therapeutic herbal vinegar | |
| CN104998051A (en) | Medicine for treating menstruation delay | |
| CN104689132A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN104189784A (en) | Traditional Chinese medicine preparation for aphtha and preparation method of traditional Chinese medicine preparation | |
| CN102283981A (en) | Drug for curing hyperthyroidism and preparation method thereof | |
| CN104069355A (en) | Medicinal composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN108379386A (en) | A kind of Chinese medicine for treating blood-heat type anaphylactoid purpura | |
| CN108465008A (en) | A kind of Chinese medicine for treating anemopyretic anaphylactoid purpura | |
| CN100534507C (en) | Oral Chinese traditional medicine composition for treating chronic enteritis | |
| CN105056196A (en) | Medicine composition for treating peptic ulcer and preparing method thereof | |
| CN104740405B (en) | A kind of Chinese medicine preparation and preparation method for treating anaphylactoid purpura renal damage | |
| CN103961562A (en) | Concentrated oral solution for treating recurrent oral ulcer by type of fire excess from yin deficiency | |
| CN104324223B (en) | A kind of Chinese medicine preparation for treating hypertension | |
| CN102406913A (en) | Chinese medicinal composition for treating melancholia | |
| CN106344838A (en) | Chinese medicinal composition for treating oral ulcer | |
| CN101129819A (en) | Orally taken traditional Chinese medicine composition for treating anaphylactoid purpura | |
| CN104645109B (en) | A kind of Chinese medicine preparation for treating liver purple plague purpura disease and preparation method thereof | |
| CN104189195B (en) | The Traditional Chinese medicine medicated bath for the treatment of neurotic skin pruritus and preparation method | |
| CN103083552B (en) | Pills for treating neurodermatitis | |
| CN110946935A (en) | Formula for treating multiple myeloma complicated with renal failure | |
| CN103463403B (en) | Pharmaceutical composition for infantile asthma | |
| CN109663064A (en) | A kind of Chinese drugs agentia for treating toothache | |
| CN108721512A (en) | A kind of Chinese drugs agentia for treating toothache |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180810 |
|
| RJ01 | Rejection of invention patent application after publication |